Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Takeda Pharmaceuticals Europe has reported new data from a clinical trial which showed that Actos has reduced the atherosclerotic burden in the coronary arteries compared to the sulphonylurea glimepiride, and prevented progression compared to baseline in patients living with type 2 diabetes.
Subscribe to our email newsletter
In his position at SRI, he also developed technologies for vibration and acoustic control of large-scale systems.
“We are pleased to add Gary Guthart to the company’s board,” said Steve P.A. Fodor, Ph.D., founder and executive chairman of Affymetrix. “His track record of operational strength, strategic vision and innovative leadership at Intuitive Surgical will be highly valuable as we re-engineer the company’s technology platform and enter new high-growth markets.”
“For the past 17 years, Affymetrix has worked to enable breakthroughs in genetic analysis,” said Gary Guthart. “I am excited to be a part of this pioneering company, which continues to accelerate scientific research and the advancement of medical care.”